ASDSA Applauds FDA for Safety Communication on Needle-less Injector Devices

ROLLING MEADOWS, Ill., Oct. 11, 2021 /PRNewswire-PRWeb/ — The American Society for Dermatologic Surgery Association (ASDSA) applauds the U.S. Food and Drug Administration (FDA) for sending out a safety communication regarding needle-less devices, such as hyaluron pens (HA pens) for injection of dermal fillers. ASDSA had earlier sounded the alarm on these devices and has resources available on these devices, including a downloadable flyer, and raised this issue with the FDA.

ASDSA members, board certified dermatologists, have found questionable social media videos in which children use these devices to self-inject and promote their use to peers. Consumers are told that these devices can create lift and fill lips, nasolabial lines, marionette lines, 11 lines and forehead wrinkles. However, the FDA recommends not using these devices; buying or using lip or dermal fillers sold directly to the public; and injecting oneself or others with any filler (FDA-approved dermal fillers are indicated for prescription use only).

“I am pleased that the FDA has taken notice of this disturbing new trend, especially that of children using these devices on social media. We urge consumers to see a board certified dermatologist before undertaking any cosmetic procedures to make sure all medical questions can be answered prior to treatment,” said ASDSA President Mathew Avram, MD, JD. “The complexity of facial anatomy requires in-depth knowledge and expertise, and patients should always have medical procedures done by a physician who also has knowledge of adverse events.”

ASDSA urges its members to report adverse event to the CAPER Registry, a partnership between ASDSA and Northwestern University’s Department of Dermatology. ASDSA members should also report applicable events to MedWatch, the FDA Safety Information and Adverse Event Reporting program.

ASDSA’s top priority is patient safety and the FDA’s safety communication on these devices will help ensure consumers know the risks of self-injecting fillers. Contact advo[email protected] if you have questions.

With a membership of 6,400+ physicians, ASDSA is a 501(c) (6) association, dedicated to education and advocacy on behalf of dermatologic surgeons and their patients. For more information, visit

Follow @ASDSAdvocacy on Facebook, Twitter, Instagram and LinkedIn!

Media Contact

Kristin Hellquist, American Society for Dermatologic Surgery Association, 847-956-9144, [email protected]

Twitter, Facebook



SOURCE American Society for Dermatologic Surgery Association

ASDSA Applauds FDA for Safety Communication on Needle-less Injector Devices WeeklyReviewer

PR Newswire Political/Government News

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

WeeklyReviewer earns commissions through affiliates of qualifying products through Amazon Associates, Fiverr Affiliates, Hostgator Affiliates, Namecheap Affiliates, NordVPN Affiliates, Semrush Affiliates, Alibaba Affiliates, Clickfunnels Affiliate, Leadpages Affiliates, Cryptohopper Affiliates, Binance Affiliates and more.

Clicking on links in WeeklyReviewer may or may not provide us commission through any qualifying purchases.

Avatar of World Reviewer Staff
World Reviewer Staff
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Related articles